Utidelone injectable Phase 1 IND approved

Beijing Biostar Pharmaceuticals incorporated in Beijing China

访问声明

Co-founder of Biostar. Specialized in molecular oncology, long engaged in the research of mechanisms underlying cell transformation and has made important contributions to the understanding of oncogenic signaling. Participated in or led the successful development of a number of novel anticancer drugs and demonstrated impressive research and development achievements. Dr. Qiu has published more than 40 research papers in prestigious scientific journals such as Nature, Cell, PNAS, Current Biology, Molecular and Cellular Biology, Chemistry and Biology, and Lancet Oncology, and is the inventor of multiple patents.

2019